Fig. 3.
Fig. 3. DDAVP-induced changes in plasma FVIII, VWF:Ag, VWF:RCo, and VWF:FVIIIB as observed in the proband. / DDAVP was administered subcutaneously, at a concentration of 0.3 μg/kg body weight.

DDAVP-induced changes in plasma FVIII, VWF:Ag, VWF:RCo, and VWF:FVIIIB as observed in the proband.

DDAVP was administered subcutaneously, at a concentration of 0.3 μg/kg body weight.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal